Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CY...

by F A Kovalenko, V V Skibitsky, A V Fendrikova
Published 2018-12-01

INTERRELATION OF ANTIHYPERTENSIVE EFFECT OF COMBINATION OF VALSARTAN AND AMLODIPINE WITH VARIOUS POLYMORPHIC VARIANTS OF GENES CYP2C9 AND CYP11B2 IN PATIENTS WITH OBESITY

by K. Yu. Lazarev, F. A. Kovalenko, I. I. Pavlyuchenko, T. B. Zabolotskikh, D. V. Syrotenko
Published 2018-05-01

EFFICIENCY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY DEPENDING ON THE POLYMORPHISM OF CYP2C9 GENE

by F. A. Kovalenko, V. V. Skibitsky, A. V. Fendrikova, K. Yu. Lazarev, I. A. Lukonin
Published 2018-05-01